One Network.
Better Care.
Making advanced clinical research accessible and integrated into everyday patient care.
About Elligo CRC
Advancing Care Through Clinical Research
Elligo Clinical Research Center (Elligo CRC), founded in 2021, is a clinical research site in Austin, TX. Led by Dr. Faith Holmes, our team conducts phase 1 dose escalation vaccine trials, as well as phase II, III, and IV clinical studies, in addition to diagnostic and device research across multiple therapeutic areas. We are a group of healthcare professionals committed to enhancing health and wellness through medical research to help find:
New Treatment Options
Developing innovative therapies that expand care possibilities and improve outcomes for diverse patient populations.
Better Treatment Outcomes
Developing innovative therapies that expand care possibilities and improve outcomes for diverse patient populations.
Disease Prevention Solutions
Advancing preventive therapies that reduce disease risk and improve long-term patient health outcomes.
Advanced Medical Devices
Testing and improving medical devices to enhance safety, precision, and overall patient care experiences.
Innovative Diagnostic Tools
Exploring new diagnostic methods that enable earlier detection and more accurate disease identification.
Our Mission
Innovative Research, Safe Care
Our mission is to provide the Austin and surrounding communities with clinical research options. Our team provides the best care for the participants we serve, prioritizing the safety of the participants and committed to offering exceptional service.
Only by clinical trials and research is it possible to find new and innovative therapies. We believe that it is vital to contribute to the understanding and development of new therapies through testing and investigational work.
Our Investigators
Meet the Experts
Behind Our Research
Since opening the Elligo Clinical Research Center in 2021, she has served as investigator on over 33 trials, including interventional, diagnostic, device, and observational studies. Her experience spans vaccines, early cancer detection, COVID detection, respiratory indications, and metabolic disorders including obesity, Type II diabetes, and OSA.
She earned her Bachelor of Science in chemistry and biology from Trevecca University and her Doctor of Medicine degree from ORU School of Medicine. She is board certified in Family Medicine and Hospice and Palliative Medicine.
She brings a decade of nursing and clinical trial/research experience in multiple therapeutic areas including Nephrology and Kidney transplantation, Endocrinology, Cardiology, Rheumatology, Dermatology, Vaccines, and Infectious diseases. She has vast experience working with both adult and pediatric patients from diverse ethnic and racial groups.
Prior to joining Elligo, Rita worked as a Research Nurse at Vanderbilt University Hospital, Nashville, TN and later as a Research Nurse Practitioner at Tekton Research, Austin, TX. She is a Certified Clinical Research Coordinator (CCRC) and a member of the Association of Clinical Research Professionals (ACRP).
He previously worked in Neurosurgery at Marcus Neuroscience Institute in Boca Raton, FL and Hospital Medicine at Dell Seton Medical Center at the University of Texas, delivering comprehensive, high-quality care to a diverse population.
He is excited to be at Elligo, contributing to scientific discovery in the areas of obesity, diabetes, sleep apnea, and more.
Hear the stories
"This trial helped me manage my diabetes — and feel in control again."
Shawn, Diabetes Trial
Testimonials provided by trial participants are personal experiences and do not necessarily represent the views of the trial sponsor. They are not a substitute for medical advice, and individual results may vary. Always consult your healthcare provider before making medical decisions.
Close Video →